Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in diabetic nephropathy.

S M Marshall1

  • 1School of Clinical Medical Sciences, 4th Floor, William Leech Building, The Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. s.m.marshall@ncl.ac.uk

Postgraduate Medical Journal
|November 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantifying movement of multiple threatened species to inform adaptive management of environmental flows.

Journal of environmental management·2021
Same author

Asking key questions in the consent process - a reply.

Anaesthesia·2018
Same author

Intrauterine growth rate in pregnancies complicated by type 1, type 2 and gestational diabetes.

Obstetric medicine·2016
Same author

Preventing kidney failure in people with diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2014
Same author

Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?

Diabetologia·2012
Same author

Non-invasive investigation of kidney disease in type 1 diabetes by magnetic resonance imaging.

Diabetologia·2011

Diabetic nephropathy, a leading cause of kidney failure, can be slowed by managing blood sugar and pressure. Aggressive treatment of microalbuminuria significantly delays progression to end-stage renal disease and cardiovascular issues.

Area of Science:

  • Nephrology
  • Diabetology
  • Cardiology

Background:

  • Diabetic nephropathy is the primary cause of end-stage renal disease globally.
  • It significantly elevates cardiovascular disease risk.
  • Microalbuminuria is the earliest clinical indicator.

Purpose of the Study:

  • To summarize management strategies for diabetic nephropathy.
  • To highlight the impact of blood glucose, blood pressure, and lipid control.
  • To discuss the role of renin-angiotensin system inhibition and other antihypertensives.

Main Methods:

  • Review of current clinical practices for managing diabetic nephropathy.
  • Emphasis on early detection and intervention through microalbuminuria monitoring.
  • Discussion of pharmacological approaches including blood pressure, glucose, and lipid management.

Related Experiment Videos

Main Results:

  • Tight control of blood glucose and blood pressure prevents microalbuminuria.
  • Aggressive management of blood pressure, glucose, and lipids slows progression post-microalbuminuria.
  • Renin-angiotensin system inhibition is crucial for reducing intraglomerular pressure.

Conclusions:

  • Effective management can reduce the progression rate of diabetic nephropathy by over 50%.
  • Comprehensive treatment strategies are vital for both renal and cardiovascular outcomes.
  • Multifaceted approaches are necessary for optimal patient care.